Researches

Displaying 41 - 50 of 4042
# Title Department Research Year
41 Crystal structure and quantum chemical calculations of 2-(2'-oxospiro[1,3-dioxolane-2,3'-indol]-1'(2'H)-yl)acetohydrazide Department of Medicinal Chemistry 2025
42 Design and synthesis of 5-substituted-2-Iminothiazolidin-4-one Derivatives as quorum sensing inhibitors against Pseudomonas aeruginosa virulence factors: An integrated study of molecular docking, dynamics, and biological assays Department of Medicinal Chemistry 2025
43 Design, synthesis, and antiproliferative activity of new 2-amino-pyrano[3,2-c]quinoline-3- carbonitriles as potential EGFR, BRAFV600E, and HER-2 inhibitors Department of Pharmaceutical Organic Chemistry 2025
44 Design, synthesis, and antiproliferative activity of new 5-ethylsulfonylindazole- 3-carbohydrazides as dual EGFR/VEGFR-2 kinases inhibitors Department of Pharmaceutical Organic Chemistry 2025
45 Design, Synthesis, and Antiproliferative Activity of Novel Indole/1,2,4-Triazole Hybrids as Tubulin Polymerization Inhibitors Department of Pharmaceutical Organic Chemistry 2025
46 Design, Synthesis, and Biological Evaluation of Novel Benzimidazole/Schiff Base Hybrid Derivatives With Potential Biological Activities Department of Pharmaceutical Organic Chemistry 2025
47 Design, synthesis, and characterization of novel 5- ethylsulfonyl-indazole-3-carboxamides as dual VEGFR-2 and EGFR inhibitors: apoptotic antiproliferative and immunomodulatory evaluations Department of Pharmaceutical Organic Chemistry 2025
48 Design, synthesis, and computational studies of novel pyrazoline-based dual EGFR/HER-2 inhibitors with apoptotic antiproliferative activity Department of Pharmaceutical Organic Chemistry 2025
49 Design, synthesis, and structural elucidation of ethyl 2-amino-5-oxo-4-aryl-4H-pyrano[3,2-c] quinoline-3-carboxylates as dual EGFR/HER-2 inhibitors endowed with antiproliferative activity Department of Pharmaceutical Organic Chemistry 2025
50 Design, synthesis, antimalarial activity, and in-silico studies of new benzimidazole/pyridine hybrids as dihydrofolate reductase inhibitors Department of Pharmaceutical Organic Chemistry 2025